Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 01, 2025 08:00 ET | Source: Neurogen Biomarking

Neurogen Announces Partnership with NeuroX, a subsidiary of American TelePhysicians

Neurogen Announces Partnership with NeuroX, a subsidiary of American TelePhysicians
February 19, 2025 08:30 ET | Source: Neurogen Biomarking

Neurogen Biomarking Announces Global Agreement with Quanterix for Use of Blood Biomarker Assay in its Patient-Initiated Blood Test to Support Early Detection of Dementia and Mild Cognitive Impairment Due to Alzheimer’s Disease

CHICAGO, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Neurogen Biomarking, the world’s first ecosystem for memory and thinking concerns announced today that they have entered into an exclusive agreement to use...
August 14, 2023 07:30 ET | Source: Transparency Market Research

Alzheimer’s Disease Biomarkers Market Predicted to Reach USD 1.7 billion by 2031, Expanding at a 7.5% CAGR Says, Transparency Market Research Inc.

Wilmington, Delaware, United States, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global Alzheimer’s disease biomarkers market is expected to be valued at US$ 953.54...
October 10, 2019 10:49 ET | Source: Oncore Pharma

Oncore Pharma Signs a Multi-Year Agreement Valued at $61.8 Million

Cambridge MA, Oct. 10, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Oncore Pharma Inc., a life sciences company specializing in blood-based biomarker tests for early cancer detection, announced...
July 21, 2016 08:30 ET | Source: DiamiR Biosciences Corp.

DiamiR Announces Oral Presentation at 2016 Alzheimer's Association International Conference

MONMOUTH JUNCTION, NJ --(Marketwired - July 21, 2016) - DiamiR, LLC, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, announced today that the...
January 11, 2016 08:02 ET | Source: DiamiR Biosciences Corp.

DiamiR Announces Research Collaboration With Johnson & Johnson Innovation

MONMOUTH JUNCTION, NJ--(Marketwired - January 11, 2016) - DiamiR, LLC, a developer of innovative minimally invasive diagnostic tests, announced today that it has entered into a research...
January 07, 2016 08:02 ET | Source: DiamiR Biosciences Corp.

DiamiR Announces Formation of Advisory Board

MONMOUTH JUNCTION, NJ--(Marketwired - January 07, 2016) - DiamiR Biosciences, a developer of innovative minimally invasive diagnostic tests for early detection and monitoring of neurodegenerative...
October 22, 2014 08:02 ET | Source: DiamiR LLC

DiamiR Announces Corporate Presentation at Life Sciences Summit 2014

MONMOUTH JUNCTION, NJ--(Marketwired - October 22, 2014) - DiamiR Biosciences, a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today that the company's...